Abbott reports solid results for its fiscal Q4

Abbott Laboratories (NYSE: ABT) is trading down in premarket on Wednesday even though it reported solid results for its fiscal fourth quarter.Why is Abbott stock down on Wednesday?Copy link to sectionInvestors seem unhappy also because the healthcare company issued a not-so encouraging guidance for the future. Abbott now forecasts its sales to climb up to 10% (excluding COVID sales) on $4.50 to$4.70 of per-share earnings in fiscal 2024. Analysts, in comparison, had called for $4.63 a share. Robert Ford – i ...